Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,654 public trials 851 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
Locations
  • NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
View all 14 locations
View Trial Details
Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions
Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations
  • Site Reference ID/Investigator# 4997 Los Angeles, California, United States
  • Site Reference ID/Investigator# 9104 Los Angeles, California, United States
  • Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States
  • Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States
View Trial Details
Completed

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

NCT00742027

Conditions
Classical Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +7 more
Locations
  • City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(2) Duarte, California, United States
  • Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) Atlanta, Georgia, United States
  • Georgia Regents University Cancer Clinical Research Unit Augusta, Georgia, United States
  • Rush University Medical Center Divisionof Hem/Onc Research(2) Chicago, Illinois, United States
View all 46 locations
View Trial Details
Completed

A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)

NCT02594267

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Houston, Texas, United States
  • Seattle Cancer Care Alliance/University of Washington Seattle, Washington, United States
View Trial Details
Completed

Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD

NCT02298283

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • CH Victor Dupouy Argenteuil, France
  • Polyclinique Bordeaux Nord Bordeaux, France
  • Centre François Baclesse Caen, France
  • CH de Chambéry Chambéry, France
View all 30 locations
View Trial Details
Completed

Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)

NCT01553786

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Université Catholique de Louvain Saint Luc Brussels, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Université Catholique de Louvain Mont Godinne Yvoir, Belgium
  • CHU d'Amiens - Hôpital Sud Amiens, France
View all 30 locations
View Trial Details
Completed

Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

NCT02676778

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Eisai Trial Site #1 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site #2 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site #1 Kashiwa, Chiba, Japan
  • Eisai Trial Site #1 Ōta, Gunma, Japan
View all 20 locations
View Trial Details

Related conditions